| ||
| OSI Pharmaceuticals, Inc. Exercises Option under Discovery and Translational ... MarketWatch (press release) "We are delighted to be a collaborator with OSI, and this milestone further demonstrates the unique insights and value AVEO's novel cancer biology platform ... See all stories on this topic » | ||
| 2010 UCD Computational Biology & Innovation PhD symposium Science Foundation Ireland The conference programme of the 2010 UCD Computational Biology & Innovation PhD symposium has a firm focus not only on innovation in scientific research but ... See all stories on this topic » |
This as-it-happens Google Alert is brought to you by Google.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment